CompletedNCT05193409
A Phase 2 Study of BNC210 for the Acute Treatment of Social Anxiety Disorder
Researchers compared 225 mg BNC210, 675 mg BNC210 and placebo, tracking side effects to assess safety in people with an anxiety condition.
Medication studyAges 18–65United States
Understand this study
What did researchers investigate?
Researchers compared 225 mg BNC210, 675 mg BNC210 and placebo, tracking side effects to assess safety in people with an anxiety condition.
Who was this study for?
Listed age limits: 18 years to 65 years.
- Listed locations
- Beverly Hills and 14 more locationsSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Study information
Study start dateStarted: February 2, 2022
- Recruitment status
- Completed
- Enrollment listed in the registry
- 151
- Sponsor
- Bionomics Limited
- Sponsor type
- Unknown or unclear
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- United States
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT05193409
- Official title
Show the full official title
A Phase 2, Randomized, Double-blind Study to Evaluate the Efficacy and Safety of BNC210 Compared to Placebo for the Acute Treatment of Social Anxiety Disorder
Recruitment & locations
CompletedBeverly Hills · Encino · Glendale
12 more locations
- New Haven
- Lauderhill
- Miami
- Miami Lakes
- Decatur
- Prairie Village
- Boston
- Princeton
- Brooklyn
- Charlotte
- Cincinnati
- Draper
Questions about this study
What did researchers investigate?
Researchers compared 225 mg BNC210, 675 mg BNC210 and placebo, tracking side effects to assess safety in people with an anxiety condition.
Who is behind this study?
The study sponsor is Bionomics Limited.
Did this study involve medication?
Yes. The study involved medication, including 225 mg BNC210, 675 mg BNC210 and Placebo.
Who was this study for?
Listed age limits: 18 years to 65 years.
Want to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
Find a study that may fit me